Phase IIB, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Intravenous Defibrotide for the Prevention and Treatment of Respiratory Distress and Cytokine Release Syndrome in COVID-19.
Jara Rubio R, Martinez-Mellado AJ, Kiwitt-Cárdenas J, Clavel JG, García-Perez B, Castro P, Diaz-Ricart M, Carrillo-Alcaraz A, López-Bernús A, Bernal Morell E, Roura A, Marín S, Ruiz-López FJ, Solana-Martinez E, Martinez-Baño D, Albacete Moreno CL, Andreu Soler E, Tellez Santoyo A, Fernández Méndez S, Noguera Velasco JA, Cebreiros Lopez I, Parrilla A, Espuny-Miró A, García-Bernal D, Blanquer M, Sánchez-Salinas A, Iniesta F, Hernandez Garcia C, Muro M, Minguela Puras A, Moreno-Docón A, Torres-Cantero AM, Munoz Garcia M, Serrano M, Iacobelli M, Carlo-Stella C, Wei LJ, Richardson PG, Moraleda JM.
Jara Rubio R, et al. Among authors: clavel jg.
Eur J Haematol. 2026 May 12. doi: 10.1111/ejh.70214. Online ahead of print.
Eur J Haematol. 2026.
PMID: 42117493